Zambon anuncia a aprovação de Hopledo® por parte da Comissão Europeia – um medicamento para adultos com doença de Parkinson e flutuações motoras moderadas a graves

Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.

Necessary cookies

Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.

Preferences

Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.

Analytical cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage.

Marketing cookies

Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.

Save settings